Lexeo Therapeutics Inc. C... (LXEO)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
5.46
-0.34 (-5.86%)
At close: Jan 15, 2025, 3:59 PM
5.49
0.55%
After-hours Jan 15, 2025, 04:00 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 |
Revenue | n/a | 654.00K | 1.66M | 518.48K |
Cost of Revenue | 1.84M | 1.15M | 13.40K | n/a |
Gross Profit | -1.84M | -491.00K | 1.64M | 518.48K |
Operating Income | -68.51M | -60.51M | -50.64M | -4.59M |
Interest Income | 2.87M | 1.32M | 15.00K | n/a |
Pretax Income | -66.39M | -59.28M | -50.62M | -5.15M |
Net Income | -66.39M | -59.28M | -50.62M | -5.15M |
Selling & General & Admin | 13.54M | 12.00M | 7.17M | 787.50K |
Research & Development | 53.13M | 49.16M | 45.12M | 4.32M |
Other Expenses | n/a | -2.00K | -155 | 4.24K |
Operating Expenses | 66.67M | 61.16M | 52.29M | 5.11M |
Interest Expense | 205.00K | 91.00K | n/a | 147.15K |
Selling & Marketing Expenses | -1.84M | n/a | n/a | n/a |
Cost & Expenses | 68.51M | 61.16M | 52.29M | 5.11M |
Income Tax | n/a | 89.00K | -155 | 147.15K |
Shares Outstanding (Basic) | 26.65M | 24.67M | 24.67M | 24.67M |
Shares Outstanding (Diluted) | 26.65M | 24.67M | 24.67M | 24.67M |
EPS (Basic) | -2.49 | -2.4 | -2.05 | -0.21 |
EPS (Diluted) | -2.49 | -2.4 | -2.05 | -0.21 |
EBITDA | -66.67M | -58.04M | -50.62M | -4.58M |
Depreciation & Amortization | 1.84M | 1.15M | 13.40K | 4.24K |